Project Details
Description
A Mulicenter, Multi-Arm, Randomized , Multi-Dose, Placebo-Controlled, Double-Blind, Phase 3 Study of Intravesical Apaziqone as a Surgical Adjuvant in the Immediate Postoperative Period in Patients Undergoing Transurethral Resection for Non-Muscle Invasiv
| Status | Finished |
|---|---|
| Effective start/end date | 12/16/16 → 12/15/17 |
Funding
- SPECTRUM PHARMACEUTICALS, INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.